Clicky

Retina Today

Retina Today Bringing you the latest research, clinical developments, and industry insights in surgical and medical retina. 👁 A Bryn Mawr Communications publication.

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, pediatric retina, posterior segment oncology, and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon. A BMC Vision publication.

Operating as usual

Applied Genetic Technologies Corporation (AGTC) reported positive 3-month interim data from its ongoing phase 2 Skyline ...
05/19/2022
AGTC Announces Positive 3-Month Interim Results from Skyline Trial of AGTC-501 for the Treatment of X-Linked Retinitis Pigmentosa - Eyewire+

Applied Genetic Technologies Corporation (AGTC) reported positive 3-month interim data from its ongoing phase 2 Skyline trial of AGTC-501, a recombinant AAV viral vector-based gene therapy targeting mutations in the RPGR gene in patients with X-linked retinitis pigmentosa (XLRP). https://bit.ly/3G3n7n1

Applied Genetic Technologies Corporation (AGTC) reported positive 3-month interim data from its ongoing phase 2 Skyline trial of AGTC-501, a

Technological advances have significantly affected how we approach ophthalmic surgery, particularly with the advent of 3...
05/17/2022
The Pros and Cons of 3D Visualization - Retina Today

Technological advances have significantly affected how we approach ophthalmic surgery, particularly with the advent of 3D visualization systems with heads-up displays. Here, we discuss the benefits of this relatively new technology—and what to watch out for when using it in the OR. https://bit.ly/3wjhFsW

These tools can be an excellent addition to the OR, but they come with a few drawbacks.

For Makoto Inoue, MD, efficiency is key when it comes to removing the vitreous. Alcon’s HyperVit dual blade vitrectomy p...
05/16/2022

For Makoto Inoue, MD, efficiency is key when it comes to removing the vitreous. Alcon’s HyperVit dual blade vitrectomy probe nearly doubles the efficiency of traditional 10K bevel cutters. Hear more about his experiences with this new tool. https://bit.ly/3wfHkT8 #ophthalmology #sponsored #thisisretina

A Primer on Diagnostic Ophthalmic UltrasoundContinued improvements to this imaging modality have made it an indispensabl...
05/15/2022

A Primer on Diagnostic Ophthalmic Ultrasound
Continued improvements to this imaging modality have made it an indispensable tool for the retina specialist. https://bit.ly/3Lf57XS

05/14/2022

Hyperglycemia in diabetes can stimulate increased vascular endothelial growth factor (VEGF), leading to fluid accumulation in the extravascular space in diabetic macular edema (DME). Watch to learn about #DME-related vision loss. https://bit.ly/DME-MOD

#RetinaWorldCongress #Sponsored by Novartis Pharmaceuticals Corporation and intended for US audiences only

With the significant changes to E/M documentation guidelines and value in 2021, now is a good time to rethink some of yo...
05/13/2022

With the significant changes to E/M documentation guidelines and value in 2021, now is a good time to rethink some of your coding patterns for various scenarios. Below are some helpful tips to help you decide how to properly code patient visits. https://bit.ly/3FLNX2F

In this article, we discuss tips and tricks of endoscopy-assisted vitrectomy used in combination with a 3D heads-up disp...
05/12/2022

In this article, we discuss tips and tricks of endoscopy-assisted vitrectomy used in combination with a 3D heads-up display system (Ngenuity, Alcon). https://bit.ly/3w6TWfk

Glenn Jaffe, MD will present a post hoc analysis of the GATHER1 Trial including the evaluation of GA lesion growth by mi...
05/10/2022

Glenn Jaffe, MD will present a post hoc analysis of the GATHER1 Trial including the evaluation of GA lesion growth by minimum distance to the fovea center at the annual Retina World Congress on May 13th at 5:30pm EST. We hope you’ll join us!

The PIVOT trial provided the first randomized longitudinal prospective imaging dataset, which enabled us to answer quest...
05/10/2022
Top 10 Lessons from The PIVOT Trial - Retina Today

The PIVOT trial provided the first randomized longitudinal prospective imaging dataset, which enabled us to answer questions not only about PnR versus PPV, but also about RRD repair in general. Based on post-hoc studies and analyses that emerged from the PIVOT trial, here are the top 10 lessons learned in the management of RRD. https://bit.ly/3Ftq3ck

Post-hoc analyses are providing actionable pearls you can use in your management of rhegmatogenous retinal detachment.

Join Evolve Medical Education LLC for a live virtual symposium on neovascular age-related macular degeneration, featurin...
05/09/2022

Join Evolve Medical Education LLC for a live virtual symposium on neovascular age-related macular degeneration, featuring Drs. Nancy Holekamp, W. Lloyd Clark, and John Kitchens! Register today: https://bit.ly/37iDu2a

No-fee #CME #Retina Series: "Modernizing Medical Retina," with Drs. Christina Weng (chair); Sophie Bakri; Peter Campochi...
05/06/2022

No-fee #CME #Retina Series: "Modernizing Medical Retina," with Drs. Christina Weng (chair); Sophie Bakri; Peter Campochiaro; Diana Do; David Eichenbaum; Basil Williams Jr.; and Glenn Yiu. View here: https://bit.ly/3InjKa8
Evolve Medical Education LLC

On Clinical Minute: Retina, Prof. Kazuaki Kadonosono joins Dr. Ramin Tadayoni to discuss the history of ILM staining in ...
05/06/2022
The History of ILM Staining - Eyetube

On Clinical Minute: Retina, Prof. Kazuaki Kadonosono joins Dr. Ramin Tadayoni to discuss the history of ILM staining in #retina surgery. Hear what it was like to be in the room where it first happened: https://bit.ly/3vQhRzO

Staining the ILM is routine in contemporary vitreoretinal surgery. How did the field arrive at this innovation, and what did the earliest data look like? On this episode of Clinical Minute: Retina, Ramin Tadayoni, MD, PhD, invites Kazuaki...

Do the demographics of patients enrolled in #retina clinical trials accurately reflect the patient populations their dru...
05/03/2022

Do the demographics of patients enrolled in #retina clinical trials accurately reflect the patient populations their drugs intend to treat? VBS members Drs. Basil Williams, Karen Jeng-Miller, M. Ali Khan, and Katherine Talcott discuss the topic on this episode of the New Retina Radio Journal Club on Eyetube: https://bit.ly/3KDNKzG

Online now! A digital interactive article with Carl C Awh MD, FASRS; Frank G Holz FEBO, FARVO; Antonia Joussen MD; Anat ...
05/02/2022

Online now! A digital interactive article with Carl C Awh MD, FASRS; Frank G Holz FEBO, FARVO; Antonia Joussen MD; Anat Loewenstein MD, MHA; and Nancy M Holekamp MD, reviews key clinical opinions around AMD and DME treatment. https://bit.ly/3L5q08n

Carl Danzig, MD, will present a post hoc analysis including patient characteristics of nascent GA progression following ...
05/01/2022

Carl Danzig, MD, will present a post hoc analysis including patient characteristics of nascent GA progression following treatment with avacincaptad pegol from the GATHER1 study at the annual meeting of The Association for Research in Vision and Ophthalmology on May 2nd at 12:38 pm MDT. Join Iveric Bio in Four Seasons Ballroom 1! #ad

Need a refresher on the status of wet AMD and GA candidates? Peter Kaiser, MD, provides an update on #retina drug candid...
04/30/2022

Need a refresher on the status of wet AMD and GA candidates? Peter Kaiser, MD, provides an update on #retina drug candidates in exudative and non-exudative disease: https://bit.ly/3i5c0yT

The Celanese team is excited to see you at #ARVO2022! Stop by booth #3309 to see what’s next in ocular #drugdelivery. Do...
04/29/2022

The Celanese team is excited to see you at #ARVO2022! Stop by booth #3309 to see what’s next in ocular #drugdelivery. Don’t miss the poster presented by Dr. Harsh Patel on treating ocular inflammation using a sustained delivery implant. #biotech #visionresearch https://bit.ly/3OaWWhF

Unsurprisingly, as imaging of the retina has grown, so has our pattern recognition of retinal biomarkers. This is furthe...
04/28/2022
An Overview of Biomarkers in Retinal Disease - Retina Today

Unsurprisingly, as imaging of the retina has grown, so has our pattern recognition of retinal biomarkers. This is further aided by the use of artificial intelligence (AI), which has allowed identification of new biomarkers and the recharacterization of previous biomarkers to improve their utility when staging disease. https://bit.ly/3LuKjwr

Advanced imaging modalities and artificial intelligence are opening doors to better diagnostics. Part 1 of a two-part series.

Management for FEVR has matured significantly over the last 20 years with improved tools and how aggressively we use the...
04/27/2022
Update in Understanding and Managing FEVR - Retina Today

Management for FEVR has matured significantly over the last 20 years with improved tools and how aggressively we use them, depending on the case. Some types of FEVR are relatively mild and remain so with control of the initial complications. Other types, however, are unrelenting and require aggressive management and frequent evaluation. https://bit.ly/3xYOiNY

New research approaches and potential therapeutics are moving the field toward improved care for these patients.

Since OCT’s wide implementation in clinical practice more than 2 decades ago, advances in technology have enabled faster...
04/25/2022
Novel OCT Findings: Catching Systemic Disease - Retina Today

Since OCT’s wide implementation in clinical practice more than 2 decades ago, advances in technology have enabled faster acquisition speed and better visualization of the #retinal microvasculature, vitreous, and choroid. This has broadened our understanding of retinal and macular pathology.

Here, we discuss some of the novel OCT findings associated with systemic conditions with an emphasis on cardiovascular disease. https://bit.ly/3MtiTqH

This imaging modality may help you care for patients beyond their ocular health.

Despite the high success rates for FTMH closure, surgery still comes with certain risks, including #retinaldetachment; i...
04/23/2022

Despite the high success rates for FTMH closure, surgery still comes with certain risks, including #retinaldetachment; infection; bleeding; phototoxicity and toxicity related to stains; and microtrauma to the retina during peeling maneuvers. In consideration of these risks, several groups have evaluated the potential for medical management of FTMHs. https://bit.ly/3MotvHp

The Celanese Corporation team is excited to see you at #ARVO2022! Stop by booth #3309 to see what’s next in ocular #drug...
04/22/2022
SUSTAINED, CONTROLLED DRUG DELIVERY TO THE EYE - ONdrugDelivery

The Celanese Corporation team is excited to see you at #ARVO2022! Stop by booth #3309 to see what’s next in ocular #drugdelivery. Don’t miss the poster presented by Dr. Harsh Patel on treating ocular inflammation using a sustained delivery implant. https://bit.ly/3OaWWhF #ad

Harsh Patel, Cyonna Holmes and Brian Wilson consider the challenges and advances in sustained-release ocular drug delivery.

This year’s Angiogenesis, Exudation, and Degeneration—hosted by Bascom Palmer Eye Institute—was another virtual marvel w...
04/22/2022
Hot Topics at Angiogenesis 2022 - Retina Today

This year’s Angiogenesis, Exudation, and Degeneration—hosted by Bascom Palmer Eye Institute—was another virtual marvel with two days of exceptional education. The robust lineup included everything from the histopathology of dry AMD to the latest therapies in the pipeline for inherited retinal diseases. Here, we share highlights from the meeting. https://bit.ly/3v32umT

Leaders in the field shared their thoughts on new imaging capabilities, the hope for a dry AMD therapy, and how to implement new treatments into practice.

Looking to strike a balance between treatment effectiveness and patient lifestyle preference when it comes to AMD and DM...
04/21/2022

Looking to strike a balance between treatment effectiveness and patient lifestyle preference when it comes to AMD and DME? Discover modern case management strategies from Carl C Awh MD, FASRS; Frank G Holz FEBO, FARVO; Antonia Joussen MD; Anat Loewenstein MD, MHA; and Nancy M Holekamp MD, in this interactive article. https://bit.ly/3L5q08n

Ophthalmic photographers have developed techniques to maximize image quality, and translating some of their learnings to...
04/20/2022
Maximizing iOCT Quality in the Surgical Suite - Retina Today

Ophthalmic photographers have developed techniques to maximize image quality, and translating some of their learnings to the OR can help you successfully capture your own iOCT images. In this article, we share our experiences and best practices for efficient and effective iOCT image acquisition. https://bit.ly/37rQ8fq

These adjustments to your workflow and instrument settings can lead to excellent image capture.

The future of robotic #vitrectomy continues to be top of mind for #retinasurgeons, with panelists at nearly every major ...
04/19/2022
Market Scope: Robotic Vitrectomy Debate Still Rages for Retina Surgeons - Eyewire+

The future of robotic #vitrectomy continues to be top of mind for #retinasurgeons, with panelists at nearly every major retina meeting in 2021 debating the topic—and without reaching consensus as to when the technology will be ready, or even whether it’s needed, according to Market Scope. https://bit.ly/3jUqqTi

The future of robotic vitrectomy continues to be top of mind for retina surgeons, with panelists at nearly every major retina meeting in 2021 debating

[NEW ISSUE] OCT is our newest toy that we just can’t stop tinkering with—now research shows it can capture retinal chang...
04/18/2022

[NEW ISSUE] OCT is our newest toy that we just can’t stop tinkering with—now research shows it can capture retinal changes associated with systemic disease, and artificial intelligence is already showing promise for analyzing OCT biomarkers of wet AMD. Many of our ORs are a high-tech space with big screens and digital overlays. https://bit.ly/3KUuOO5

Ongoing innovation in #retina means that the status of drug candidates in the wet AMD and GA pipeline is always changing...
04/17/2022
2022 Retina Pipeline: A View Into Ongoing Innovation - Retina Today

Ongoing innovation in #retina means that the status of drug candidates in the wet AMD and GA pipeline is always changing. Drs. Peter Kaiser and Marielle Mahan serve as your guides to the latest updates in this interactive graphic: https://bit.ly/3i5c0yT

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight...

What's inside 'The Why and How of Going Solo?'The #PracticeManagement column walks you through how to make tough staffin...
04/17/2022

What's inside 'The Why and How of Going Solo?'
The #PracticeManagement column walks you through how to make tough staffing changes, while Coding Advisor provides much-needed tips for avoiding claim denials. Oh, and if you already have a successful private practice, Your Money column can help you prepare to sell that business to start your next adventure. Read the full supplement: https://bit.ly/3M4xPLC

Address

1008 Upper Gulph Rd
Wayne, PA
19087

Telephone

(484) 680-6632

Alerts

Be the first to know and let us send you an email when Retina Today posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Retina Today:

Videos

Nearby media companies


Other Media/News Companies in Wayne

Show All

Comments

Applied Genetic Technologies Corporation (AGTC) reported positive 3-month interim data from its ongoing phase 2 Skyline trial of AGTC-501, a recombinant AAV viral vector-based gene therapy targeting mutations in the RPGR gene in patients with X-linked retinitis pigmentosa (XLRP). https://bit.ly/3G3n7n1
Technological advances have significantly affected how we approach ophthalmic surgery, particularly with the advent of 3D visualization systems with heads-up displays. Here, we discuss the benefits of this relatively new technology—and what to watch out for when using it in the OR. https://bit.ly/3wjhFsW
For Makoto Inoue, MD, efficiency is key when it comes to removing the vitreous. Alcon’s HyperVit dual blade vitrectomy probe nearly doubles the efficiency of traditional 10K bevel cutters. Hear more about his experiences with this new tool. https://bit.ly/3wfHkT8 #ophthalmology #sponsored #thisisretina
A Primer on Diagnostic Ophthalmic Ultrasound Continued improvements to this imaging modality have made it an indispensable tool for the retina specialist. https://bit.ly/3Lf57XS
Hyperglycemia in diabetes can stimulate increased vascular endothelial growth factor (VEGF), leading to fluid accumulation in the extravascular space in diabetic macular edema (DME). Watch to learn about #DME-related vision loss. https://bit.ly/DME-MOD #RetinaWorldCongress #Sponsored by Novartis Pharmaceuticals Corporation and intended for US audiences only
With the significant changes to E/M documentation guidelines and value in 2021, now is a good time to rethink some of your coding patterns for various scenarios. Below are some helpful tips to help you decide how to properly code patient visits. https://bit.ly/3FLNX2F
In this article, we discuss tips and tricks of endoscopy-assisted vitrectomy used in combination with a 3D heads-up display system (Ngenuity, Alcon). https://bit.ly/3w6TWfk
Herein we describe a child with bilateral RB who presented at the initial ophthalmic diagnosis with a suprasellar mass. https://bit.ly/3M8QSVN
Glenn Jaffe, MD will present a post hoc analysis of the GATHER1 Trial including the evaluation of GA lesion growth by minimum distance to the fovea center at the annual Retina World Congress on May 13th at 5:30pm EST. We hope you’ll join us!
The PIVOT trial provided the first randomized longitudinal prospective imaging dataset, which enabled us to answer questions not only about PnR versus PPV, but also about RRD repair in general. Based on post-hoc studies and analyses that emerged from the PIVOT trial, here are the top 10 lessons learned in the management of RRD. https://bit.ly/3Ftq3ck
Join Evolve Medical Education LLC for a live virtual symposium on neovascular age-related macular degeneration, featuring Drs. Nancy Holekamp, W. Lloyd Clark, and John Kitchens! Register today: https://bit.ly/37iDu2a
No-fee #CME #Retina Series: "Modernizing Medical Retina," with Drs. Christina Weng (chair); Sophie Bakri; Peter Campochiaro; Diana Do; David Eichenbaum; Basil Williams Jr.; and Glenn Yiu. View here: https://bit.ly/3InjKa8 Evolve Medical Education LLC